Back to top
more

NanoString Technologies, Inc. (NSTG)

(Delayed Data from NSDQ)

$27.96 USD

27.96
266,767

+0.86 (3.17%)

Updated May 3, 2019 04:00 PM ET

After-Market: $27.94 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

What's in Store for Abbott Laboratories (ABT) in Q1 Earnings?

by Zacks Equity Research

Excluding COVID testing sales, Abbott's (ABT) worldwide Diagnostic sales are expected to have demonstrated strong growth in Q1 on the continuous rollout of Alinity, Abbott's suite of diagnostic instruments.

Quest Diagnostics (DGX) Q1 Earnings to Grow on Base Business

by Zacks Equity Research

Quest Diagnostics (DGX) is expected to report a strong first half of Q1 with a growing number of cases and then a dull second half on gradual stabilization in testing demand.

Does NanoString (NSTG) Have the Potential to Rally 117% as Wall Street Analysts Expect?

by Zacks Equity Research

The mean of analysts' price targets for NanoString (NSTG) points to an 116.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

How Much Upside is Left in NanoString (NSTG)? Wall Street Analysts Think 122%

by Zacks Equity Research

The mean of analysts' price targets for NanoString (NSTG) points to a 121.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Does NanoString (NSTG) Have the Potential to Rally 104% as Wall Street Analysts Expect?

by Zacks Equity Research

The average of price targets set by Wall Street analysts indicates a potential upside of 103.7% in NanoString (NSTG). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

NanoString Technologies (NSTG) Reports Q3 Loss, Misses Revenue Estimates

by Zacks Equity Research

NanoString (NSTG) delivered earnings and revenue surprises of -30.19% and -0.52%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

NanoString Technologies (NSTG) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

by Zacks Equity Research

NanoString (NSTG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

NanoString Technologies (NSTG) Reports Q2 Loss, Tops Revenue Estimates

by Zacks Equity Research

NanoString (NSTG) delivered earnings and revenue surprises of -7.14% and 2.81%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

NanoString Technologies (NSTG) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

by Zacks Equity Research

NanoString (NSTG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

NanoString Technologies (NSTG) Reports Q1 Loss, Tops Revenue Estimates

by Zacks Equity Research

NanoString (NSTG) delivered earnings and revenue surprises of -6.90% and 5.19%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

Urmimala Biswas headshot

Medical Product Stock Q1 Earnings on May 10: MRVI, TGTX & More

by Urmimala Biswas

The sector's Q1 results are likely to reflect solid earnings and revenue growth on strong base business recovery.

NanoString Technologies (NSTG) Reports Q4 Loss, Tops Revenue Estimates

by Zacks Equity Research

NanoString (NSTG) delivered earnings and revenue surprises of -12.77% and 1.72%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: NanoString Technologies (NSTG) Q4 Earnings Expected to Decline

by Zacks Equity Research

NanoString (NSTG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

NanoString Technologies (NSTG) Reports Q3 Loss, Tops Revenue Estimates

by Zacks Equity Research

NanoString (NSTG) delivered earnings and revenue surprises of 8.20% and 5.68%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

Will NanoString Technologies (NSTG) Report Negative Earnings Next Week? What You Should Know

by Zacks Equity Research

NanoString (NSTG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

New Strong Sell Stocks for September 22nd

by Zacks Equity Research

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today.

New Strong Sell Stocks for August 26th

by Zacks Equity Research

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today.

NanoString Technologies (NSTG) Reports Q2 Loss, Tops Revenue Estimates

by Zacks Equity Research

NanoString (NSTG) delivered earnings and revenue surprises of -28.57% and 40.00%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Trina Mukherjee headshot

Medical Products Stock Earnings on Aug 10: CGC, SDGR & More

by Trina Mukherjee

Despite the impact of the pandemic on the second quarter, Medical Product companies have shown strength on the back of huge adoption of COVID-19 related healthcare-support products and services.

Will NanoString Technologies (NSTG) Report Negative Earnings Next Week? What You Should Know

by Zacks Equity Research

NanoString (NSTG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

NanoString Technologies (NSTG) Surges: Stock Moves 10.3% Higher

by Zacks Equity Research

NanoString Technologies (NSTG) saw a big move last session, as its shares jumped more than 10% on the day, amid huge volumes.

NanoString Technologies (NSTG) Reports Q1 Loss, Tops Revenue Estimates

by Zacks Equity Research

NanoString (NSTG) delivered earnings and revenue surprises of -34.69% and 7.86%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Why NanoString Technologies (NSTG) Stock Might be a Great Pick

by Zacks Equity Research

NanoString Technologies (NSTG) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.

Quidel (QDEL) Looks Good: Stock Adds 10.8% in Session

by Zacks Equity Research

Quidel (QDEL) saw a big move last session, as its shares jumped nearly 11% on the day, amid huge volumes.

Top Ranked Momentum Stocks to Buy for March 3rd

by Zacks Equity Research

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, March 3rd